VIIV-201480

Study Sponsor: ViiV

Study Title

A Phase I, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 in Subjects with Severe Renal Impairment and Healthy Matched Control Subjects

Medicine or Vaccine (generic name)

cabotegravir

Sponsor Identification Number

201480

Trial Registry Identification Number(#'s)

NCT02354937

Medical Condition

Infection, Human Immunodeficiency Virus

Phase

Phase 1

Link to study details on the ViiV Clinical Study Register

https://www.viiv-studyregister.com/en/study/?id=201480

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02354937

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

The data for this study is available in CDISC format.

Date Added to this Site

May 2020